AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 16.18 USD -1.34% Market Closed
Market Cap: 717.4m USD

During the last 3 months AxoGen Inc insiders have not bought any shares, and sold 364.5k USD worth of shares. The stock price has dropped by 12% over this period (open performance analysis).

The last transaction was made on Mar 19, 2025 by Devinney Erick Wayne (Director) , who sold 264.4k USD worth of AXGN shares.

Last Transactions:
Devinney Erick Wayne
Director
$-264.4k
Wendell Amy Mcbride
Chief Financial Officer
$-100.1k
Tyndall Joseph A.
Director
$+26.5k
Devinney Erick Wayne
Director
$-5.5k
Zaderej Karen L.
Chief Executive Officer
$-253.7k
Scopelianos Angelo
Chief Financial Officer
$-40.3k
Donovan Michael Patrick
Chief Financial Officer
$-5.5k
Freitag Gregory Gene
General Counsel and Director
$-225k
Donovan Michael Patrick
Chief Financial Officer
$-319.9k
Mariani Peter J
Chief Financial Officer
$-10.6k
Wendell Amy Mcbride
Chief Financial Officer
$+62.2k
Burke William P. Mr.
Chief Financial Officer
$+65.6k
Neels Guido J
Chief Financial Officer
$+61.1k
Freitag Gregory Gene
General Counsel and Director
$-108.1k
Freitag Gregory Gene
General Counsel and Director
$-25.9k
Mariani Peter J
Chief Financial Officer
$-136.7k
Mariani Peter J
Chief Financial Officer
$-214.2k
Mariani Peter J
Chief Financial Officer
$-126.5k
Freitag Gregory Gene
General Counsel and Director
$-165.6k
Freitag Gregory Gene
General Counsel and Director
$-162.5k
Freitag Gregory Gene
General Counsel and Director
$-86.2k
Freitag Gregory Gene
General Counsel and Director
$-255.4k
Zaderej Karen L.
Chief Executive Officer
$-271.5k
Donovan Michael Patrick
Chief Financial Officer
$-38.8k
Martinez Maria D.
Director
$-50k
Freitag Gregory Gene
General Counsel and Director
$-529.4k
Donovan Michael Patrick
Chief Financial Officer
$-34.6k
Zaderej Karen L.
Chief Executive Officer
$-1.3m
Donovan Michael Patrick
Chief Financial Officer
$-30.3k
Billet Isabelle
EVP, General Counsel and Chief Compliance Officer
$-11.6k
Scopelianos Angelo
Chief Financial Officer
$-10.1k
Donovan Michael Patrick
Chief Financial Officer
$-10.1k
View All Transactions

During the last 3 months AxoGen Inc insiders have not bought any shares, and sold 364.5k USD worth of shares. The stock price has dropped by 12% over this period (open performance analysis).

The last transaction was made on Mar 19, 2025 by Devinney Erick Wayne (Director) , who sold 264.4k USD worth of AXGN shares.

Sold
0-3
months
364.5k USD
2
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
1
26.5k USD
9-12
months
No Insider Transactions
0
0 USD

AxoGen Inc
Insider Trading Chart

AxoGen Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

AxoGen Inc
Last Insider Transactions

Global
Insiders Monitor

AxoGen Inc
Glance View

Market Cap
714.3m USD
Industry
Health Care

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.

AXGN Intrinsic Value
11.68 USD
Overvaluation 28%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top